Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With Thrombectomy

Recruiting

Phase N/A Results N/A

Summary of Purpose

The aim of this study is to find out if DS-1040b is safe and tolerable in acute ischemic stroke patients with thrombectomy. Four groups will receive different doses of DS-1040b by intravenous infusion for 6 hours. Groups with the lowest dose will start. When it is determined that each dose is safe and tolerable, the next higher dose will be given to the next group.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 November 2017.

30 Jul 2017 19 Jun 2017 1 Jun 2018 1 Sep 2018 1 Nov 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts